127 related articles for article (PubMed ID: 32468825)
1. Intra-Pancreatic Insulin Nourishes Cancer Cells: Do Insulin-Receptor Antagonists such as PGG and EGCG Play a Role?
Hu L; Chen X; Qiu S; Yang J; Liu H; Zhang J; Zhang D; Wang F
Am J Chin Med; 2020; 48(4):1005-1019. PubMed ID: 32468825
[TBL] [Abstract][Full Text] [Related]
2. β-Pentagalloyl-Glucose Sabotages Pancreatic Cancer Cells and Ameliorates Cachexia in Tumor-Bearing Mice.
Yang J; Wang F; Chen X; Qiu S; Cui L; Hu L
Am J Chin Med; 2019; 47(3):675-689. PubMed ID: 30966770
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-Gallate Decreases Hypoxia-Inducible Factor-1 in Pancreatic Cancer Cells.
Hu L; Xu X; Chen X; Qiu S; Li Q; Zhang D; Wang F
Am J Chin Med; 2023; 51(3):761-777. PubMed ID: 36867109
[TBL] [Abstract][Full Text] [Related]
4. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
Shankar S; Marsh L; Srivastava RK
Mol Cell Biochem; 2013 Jan; 372(1-2):83-94. PubMed ID: 22971992
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor signaling activated by penta-O-galloyl-α-D: -glucopyranose induces p53 and apoptosis in cancer cells.
Cao Y; Evans SC; Soans E; Malki A; Liu Y; Liu Y; Chen X
Apoptosis; 2011 Sep; 16(9):902-13. PubMed ID: 21671008
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 increases glycolysis in pancreatic cancer cells and triggers cachectic states.
Hu L; Xu X; Li Q; Chen X; Yuan X; Qiu S; Yao C; Zhang D; Wang F
FASEB J; 2021 Aug; 35(8):e21826. PubMed ID: 34320244
[TBL] [Abstract][Full Text] [Related]
7. Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway.
Li Y; Kim J; Li J; Liu F; Liu X; Himmeldirk K; Ren Y; Wagner TE; Chen X
Biochem Biophys Res Commun; 2005 Oct; 336(2):430-7. PubMed ID: 16137651
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate and penta-O-galloyl-β-D-glucose inhibit protein phosphatase-1.
Kiss A; Bécsi B; Kolozsvári B; Komáromi I; Kövér KE; Erdődi F
FEBS J; 2013 Jan; 280(2):612-26. PubMed ID: 22260360
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose in murine macrophage cells.
Lee SJ; Lee IS; Mar W
Arch Pharm Res; 2003 Oct; 26(10):832-9. PubMed ID: 14609132
[TBL] [Abstract][Full Text] [Related]
10. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth.
Chai Y; Lee HJ; Shaik AA; Nkhata K; Xing C; Zhang J; Jeong SJ; Kim SH; Lu J
Breast Cancer Res; 2010; 12(5):R67. PubMed ID: 20809980
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice.
Song EK; Hur H; Han MK
Arch Pharm Res; 2003 Jul; 26(7):559-63. PubMed ID: 12934649
[TBL] [Abstract][Full Text] [Related]
12. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways.
Huh JE; Lee EO; Kim MS; Kang KS; Kim CH; Cha BC; Surh YJ; Kim SH
Carcinogenesis; 2005 Aug; 26(8):1436-45. PubMed ID: 15845650
[TBL] [Abstract][Full Text] [Related]
13. A novel small molecule 1,2,3,4,6-penta-O-galloyl-α-D-glucopyranose mimics the antiplatelet actions of insulin.
Perveen R; Funk K; Thuma J; Wulf Ridge S; Cao Y; Akkerman JW; Chen X; Akbar H
PLoS One; 2011; 6(11):e26238. PubMed ID: 22073153
[TBL] [Abstract][Full Text] [Related]
14. Orally efficacious novel small molecule 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose selectively and potently stimulates insulin receptor and alleviates diabetes.
Cao Y; Li Y; Kim J; Ren Y; Himmeldirk K; Liu Y; Qian Y; Liu F; Chen X
J Mol Endocrinol; 2013; 51(1):15-26. PubMed ID: 23549408
[TBL] [Abstract][Full Text] [Related]
15. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
Hu H; Lee HJ; Jiang C; Zhang J; Wang L; Zhao Y; Xiang Q; Lee EO; Kim SH; Lü J
Mol Cancer Ther; 2008 Sep; 7(9):2681-91. PubMed ID: 18790750
[TBL] [Abstract][Full Text] [Related]
16. Involvement of autophagy induction in penta-1,2,3,4,6-O-galloyl-β-D-glucose-induced senescence-like growth arrest in human cancer cells.
Dong Y; Yin S; Jiang C; Luo X; Guo X; Zhao C; Fan L; Meng Y; Lu J; Song X; Zhang X; Chen N; Hu H
Autophagy; 2014 Feb; 10(2):296-310. PubMed ID: 24389959
[TBL] [Abstract][Full Text] [Related]
17. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Shankar S; Ganapathy S; Hingorani SR; Srivastava RK
Front Biosci; 2008 Jan; 13():440-52. PubMed ID: 17981559
[TBL] [Abstract][Full Text] [Related]
18. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation.
Li M; He Z; Ermakova S; Zheng D; Tang F; Cho YY; Zhu F; Ma WY; Sham Y; Rogozin EA; Bode AM; Cao Y; Dong Z
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):598-605. PubMed ID: 17372258
[TBL] [Abstract][Full Text] [Related]
19. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.
Hu H; Chai Y; Wang L; Zhang J; Lee HJ; Kim SH; Lü J
Mol Cancer Ther; 2009 Oct; 8(10):2833-43. PubMed ID: 19825802
[TBL] [Abstract][Full Text] [Related]
20. Glucose- and Triglyceride-lowering Dietary Penta-O-galloyl-α-D-Glucose Reduces Expression of PPARγ and C/EBPα, Induces p21-Mediated G1 Phase Cell Cycle Arrest, and Inhibits Adipogenesis in 3T3-L1 Preadipocytes.
Liu X; Malki A; Cao Y; Li Y; Qian Y; Wang X; Chen X
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):308-16. PubMed ID: 25988880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
